Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
49,100,735
-
Share change
-
+8,136,312
-
Total reported value
-
$24,801,289
-
Price per share
-
$0.51
-
Number of holders
-
55
-
Value change
-
-$2,471,956
-
Number of buys
-
28
-
Number of sells
-
45
Institutional Holders of AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) as of Q2 2022
As of 30 Jun 2022,
AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,100,735 shares.
The largest 10 holders included
Bain Capital Life Sciences Investors, LLC, PICTET ASSET MANAGEMENT SA, Sio Capital Management, LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, Nantahala Capital Management, LLC, BAKER BROS. ADVISORS LP, Rock Springs Capital Management LP, GREAT POINT PARTNERS LLC, VANGUARD GROUP INC, and ORBIMED ADVISORS LLC.
This page lists
55
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.